Camp4 Therapeutics Corp business relationships
Companies named in Camp4 Therapeutics Corp’s 10-K filed 2026-03-05, and public companies whose annual reports name Camp4 Therapeutics Corp. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 5.2 / 10
- AI naming
- 46 / 100 Top 1% in its category
- Agent readiness
- 35 / 100
- AI adoption
- 0 / 100
Named in Camp4 Therapeutics Corp’s annual report 6
“In September 2024, the Company entered into a Collaboration and License Agreement (the "BioMarin Agreement") with BioMarin Pharmaceutical Inc. ("BioMarin").” SEC filing
“The Company assessed this arrangement in accordance with ASC 606 and concluded that GSK is a customer and there is one combined performance obligation, which includes performance of R&D activities in accordance with a contractual work plan, participation in a joint steering committee, the grant of a...” SEC filing
“For example, our ability to receive certain development and commercial milestone payments and royalties from GSK will depend in significant part on GSK's success and diligence in advancing any licensed compounds and licensed products through development, regulatory approval and commercialization.” SEC filing
“Research, Collaboration and License Agreement with GSK” SEC filing
“There was no collaboration revenue under the GSK Agreement recognized during the year ended December 31, 2025.” SEC filing
“The proprietary intellectual property licensed pursuant to this agreement is related to certain legacy programs we are not pursuing, which were subsequently sublicensed to Fulcrum Therapeutics, Inc. ("Fulcrum"), as described below.” SEC filing
Companies whose annual reports name Camp4 Therapeutics Corp 2
“Exclusive License Agreement, dated July 6, 2021, by and between OPKO Health, Inc. and CAMP4 Therapeutics Corporation, filed with the Company's Quarterly Report on Form 10⁃Q filed with the Securities and Exchange Commission on July 29, 2021 for the Company's three-month period ended June 30, 2021, an...” SEC filing
“the progress and results of our exclusive global license agreement with CAMP4 Therapeutics Corp., or CAMP4;” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.